Clarification (219)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Companies respond to BSE surveillance queries regarding significant increase in trading volume, clarifying that movements are market driven … | |||||||||||||||
Companies respond to BSE surveillance queries regarding significant increase in trading volume, clarifying that movements are market driven with no pending price-sensitive information.
| |||||||||||||||
Companies provide clarifications to BSE regarding significant increases in trading volume and price movements in their securities. | |||||||||||||||
Companies provide clarifications to BSE regarding significant increases in trading volume and price movements in their securities.
| |||||||||||||||
BSE seeks clarifications from companies regarding news articles published on January 09, 2026, including Indian Energy Exchange Limited's … | |||||||||||||||
BSE seeks clarifications from companies regarding news articles published on January 09, 2026, including Indian Energy Exchange Limited's response about APTEL hearing on market coupling order.
| |||||||||||||||
Indian Energy Exchange clarifies news article about APTEL hearing on its petition challenging CERC's market coupling order, confirms no … | |||||||||||||||
Indian Energy Exchange clarifies news article about APTEL hearing on its petition challenging CERC's market coupling order, confirms no undisclosed material information affecting stock price movement.
| |||||||||||||||
Stock exchanges sought clarifications from Bharat Petroleum Corporation Limited and Vedanta Limited regarding news articles about their … | |||||||||||||||
Stock exchanges sought clarifications from Bharat Petroleum Corporation Limited and Vedanta Limited regarding news articles about their business contracts and legal matters.
| |||||||||||||||
BSE circular containing clarifications from Bharat Petroleum Corporation Limited and Vedanta Limited on recent news articles about their … | |||||||||||||||
BSE circular containing clarifications from Bharat Petroleum Corporation Limited and Vedanta Limited on recent news articles about their business operations.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
Reliance Industries Limited and Indian Energy Exchange Limited provide clarifications to BSE regarding news articles about Russian oil … | |||||||||||||||
Reliance Industries Limited and Indian Energy Exchange Limited provide clarifications to BSE regarding news articles about Russian oil deliveries and APTEL hearing respectively.
| |||||||||||||||
Three companies provide clarifications to BSE regarding price movements and volume increases in their securities. | |||||||||||||||
Three companies provide clarifications to BSE regarding price movements and volume increases in their securities.
| |||||||||||||||